Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?

Leuk Lymphoma. 2014 Dec;55(12):2675-7. doi: 10.3109/10428194.2014.918971. Epub 2014 Jun 27.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Lymphoma, Follicular / drug therapy*